Last reviewed · How we verify
live attenuated zoster vaccine — Competitive Intelligence Brief
phase 3
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
live attenuated zoster vaccine (live attenuated zoster vaccine) — Changchun BCHT Biotechnology Co.. The live attenuated zoster vaccine works by introducing a weakened form of the varicella-zoster virus to stimulate an immune response.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| live attenuated zoster vaccine TARGET | live attenuated zoster vaccine | Changchun BCHT Biotechnology Co. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- live attenuated zoster vaccine CI watch — RSS
- live attenuated zoster vaccine CI watch — Atom
- live attenuated zoster vaccine CI watch — JSON
- live attenuated zoster vaccine alone — RSS
Cite this brief
Drug Landscape (2026). live attenuated zoster vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/live-attenuated-zoster-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab